STAAR Surgical Company Aktie
WKN: 870353 / ISIN: US8523123052
|
08.01.2024 13:55:06
|
STAAR Surgical Posts Better Than Expected Preliminary Q4 Revenue
(RTTNews) - STAAR Surgical Co. (STAA) Monday announced its preliminary revenue for the fourth quarter and fiscal 2023. The results were better than its view.
Preliminary quarterly revenue is reported at around $76.5 million and yearly revenue at around $322.5 million.
On average, ten analysts polled by Thomson Reuters had expected revenue of $74.23 million for the quarter and $320.5 million for the year. Analysts' estimates typically exclude special items.
"Fiscal 2023 was a year of positive market share gains, sales growth, and continued profitability for STAAR. Our teams finished the year on a strong note with global ICL sales increasing 22% in the fourth quarter including 26% growth in APAC," said Tom Frinzi, CEO of STAAR Surgical.
Further, the company expects net sales for fiscal 2024 to be around $335 million to $340 million. The Street view for revenue is $366.8 million.
The complete fourth quarter and fiscal year results are expected on or about February 21.
In pre-market activity, STAAR Surgical shares are trading at $27.71, down 2.76% on the Nasdaq.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu STAAR Surgical Companymehr Nachrichten
|
05.08.25 |
Ausblick: STAAR Surgical Company veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net) | |
|
06.05.25 |
Ausblick: STAAR Surgical Company vermeldet Zahlen zum jüngsten Quartal (finanzen.net) |
Analysen zu STAAR Surgical Companymehr Analysen
Aktien in diesem Artikel
| STAAR Surgical Company | 23,08 | 8,41% |
|